LOCUS BIOSCIENCES INC
About the company
Locus Biosciences (Locus) is a clinical-stage pharmaceutical company based in Morrisville (Research Triangle Park), North Carolina, founded in 2015 as an NCSU spin‑out. It develops CRISPR-Cas3–enhanced bacteriophage therapies (“crPhage”) targeting drug-resistant bacterial infections. via Wikipedia
What they took
These are obligated federal contract dollars from awards of $1 million or more. They are not profit, revenue, a contract ceiling, or the company's full federal total. Data loaded as of Oct 19, 2026.
LOCUS BIOSCIENCES INC
Federal contract obligations (≥$1M) by awarding agency.
| Agency | FY2027 |
|---|---|
| Department of Health and Human Services | $5.3M |
- $5.3M
Department of Health and Human Services
National Institutes of Health · 2026-10-16 · NAICS 541714 · PSC AN12
tx|CONT_AWD_75N93025C00035_7529_-NONE-_-NONE-|2026-10-16|5271052.00|P00005Source
What they spent
This is the annual total reported in lobbying filings. It is not labeled as spending on a specific contract.
No lobbying-company match is attached yet.
Donation totals combine PAC and employee-attributed individual records where the contractor resolves to a donor.
Who they funded
We found no federal PAC and no employee giving on file for this company. Plenty of private firms never set one up.